MENU
CARA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cara Therapeutics (CARA) Ownership - Who owns Cara Therapeutics?
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
400 Atlantic Street
Phone
+1 203 406-3700
Employees
55
Web
https://www.caratherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.33M
P/E Ratio
N/A
Total Cash
37.9M
Projected Growth
N/A
Total Debt
N/A
Revenue
7.14M
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash/Share
24.86
Total Debt/Equity
N/A
Revenue/Share
4.69 USD as % of share price
Fundamentals
CARA
Capitalization
24.3M
P/E Ratio
N/A
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash
37.9M
Total Cash/Share
24.86
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.69%
Revenue
7.14M
ROE
N/A
Book Value
-4.59M
P/B Ratio
33.11
Cash Flow
N/A
Earnings
-15.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
11.03
Current Revenue Per Employee
26454.54
Dividends Per Share - Security
N/A
EBITDA
-62.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-83.53
Shares Held By Institutions
7.84M
Shares Outstanding - Current
1.53M
Total Liabilities
48.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-9.315
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Atlantic Street
Phone
+1 203 406-3700
Employees
55
Web
https://www.caratherapeutics.com